REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & NephewAnnouncement

14/05/2021 16:00

RNS Number : 7324Y
  
Smith & Nephew Plc
  
14 May 2021
  
 

SMITH & NEPHEW PLC
 
14 May 2021
 
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
 



Reason for the notification




Initial notification /Amendment


Initial notification




Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




Name


Smith & Nephew plc




LEI


213800ZTMDN8S67S1H61




Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




Description of the financial instrument, type of instrument
 


Smith & Nephew plc ordinary shares of USD 0.20 each
 




Identification code


ISIN: GB0009223206




Nature of the transaction


Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2020 final dividend payment on 12 May 2021.




Date of Transaction


2021 - 05 - 12




Place of Transaction


London Stock Exchange (XLON)



 



Name (Position)


Director / PDMR


Price


Volume


Aggregated information


Total Ordinary Share Holding following the transaction *


Total Ordinary Share Holding as a % of the Company's ISC following the transaction *




Bradley Cannon
(President Sports Medicine & ENT)


PDMR


£15.269779


129.64031


N/A Single Transaction


77,295.40344 (including 2,101.64550 in ADS')


0.00873%




Phil Cowdy
(Chief Business Development & Corporate Affairs Officer)


PDMR


£15.269779


112.08811


N/A Single Transaction


45,410.28786


0.00513%




Myra Eskes
(President APAC Region)


PDMR


£15.269779


197.38513


N/A Single Transaction


18,332.32816


0.00207%




Simon Fraser
(President Advanced Wound Management)


PDMR


£15.269779


92.76422


N/A Single Transaction


8,615.56333


0.00097%




Mark Gladwell
(President Operations & GBS)


PDMR


£15.269779


96.46099


N/A Single Transaction


96.90438


0.00001%




Melissa Guerdan
(Chief Quality & Regulatory Affairs Officer)


PDMR


£15.269779


99.85666


N/A Single Transaction


9,274.28002


0.00105%




Skip Kiil
(President Orthopaedics)


PDMR


£15.269779


99.50036


N/A Single Transaction


12,128.03780


0.00137%




Catheryn O'Rourke
(Chief Legal & Compliance Officer)


PDMR


£15.269779


583.31782


N/A Single Transaction


82,100.55347 (including 5,818.25734 in ADS')


0.00928%




Susan Swabey
(Company Secretary)


PDMR


£15.269779


190.40720


N/A Single Transaction


49,416.24672


0.00558%



 
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
 
 
Vickie Reuben  
Deputy Company Secretary
Smith & Nephew plc
 
Tel:  +44 (0)1923 477410
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHFLFESESISLIL